13 May 2025
Holland and Barrett, the leading health and wellness retailer, has announced the renewal of its long-term partnership with Al Khayyat Investments (AKI) in the United Arab Emirates (UAE), a key growth market in the Middle East. The new agreement, signed in Dubai by AKI Pharma and BinSina Pharmacy CEO Dr. Doaa Hassan Marouf and Holland and Barrett’s International CEO Alex Dower, marks the next chapter in the successful 15-year long collaboration.
Founded in 1982, Al Khayyat Investments (AKI) is an Emirati family-owned conglomerate regarded as a pioneer in several industries in the Middle East, operating across multiple sectors, spanning pharmaceuticals, medical equipment, retail, food and non-food consumer goods, fitness, automotive, environmental services, and contracting. AKI’s diverse portfolio make it the perfect partner to accelerate growth in UAE.
Holland and Barrett’s International CEO Alex Dower commented on the agreement: “I am delighted that our strategic partnership with AKI in the UAE has been extended for the long term.”
“By combining Holland and Barrett’s 155 years of heritage and our award-winning advice and product innovation with AKI’s market-leading position in the UAE, we’re looking forward to furthering our mission to make health and wellness a way of life for everyone in the UAE.”
CEO of AKI Pharma & BinSina Pharmacy, Doaa Marouf, added: “We are thrilled to announce we are continuing our long-standing partnership. Holland and Barrett has been part of the AKI family for over 15 years, and with strong customer growth already being delivered we have exciting plans for expanding the Holland and Barrett reach in the UAE in the years to come.”